Systemic lupus erythematosus (SLE) is a common autoimmune disorder with a complex and poorly understood immunopathogenesis. However, a pathogenic role for the T helper type 17 (Th17) axis was demonstrated by many studies, while regulatory T cells (T regs ) were shown to mediate protection. Recently, we and others characterized a novel and independent T cell population expressing both the T reg characteristic transcription factor forkhead box protein 3 (FoxP3) and the Th17-defining retinoic acid receptor-related orphan nuclear receptor gt (RORgt). Studies in a model of acute glomerulonephritis unveiled potent regulatory, but also proinflammatory, functions of RORgt 1 FoxP3 1 T regs . This bi-functional nature prompted us to suggest the name 'biT regs '. Importantly, the pathogenic biT reg effects were dependent upon expression of RORgt. We thus aimed to evaluate the contribution of RORgt 1 FoxP3 1 biT regs to pristane-induced SLE and explored the therapeutic potential of interference with RORgt activation. Our analyses revealed expansion of IL-17 producing biT regs in a distinctive time-course and organ-specific pattern, coincident with the development of autoimmunity and tissue injury. Importantly, specific ablation of RORgt activation in endogenous biT regs resulted in significant amelioration of pristane-induced pulmonary vasculitis and lupus nephritis. As potential mechanisms underlying the observed protection, we found that secretion of IL-17 by biT regs was abrogated completely in FoxP3 Cre 3 RORC fl/fl mice. Furthermore, T regs showed a more activated phenotype after cell-specific inactivation of RORgt signalling. Finally, and remarkably, biT regs were found to potently suppress anti-inflammatory Th2 immunity in a RORgt-dependent manner. Our study thus identifies biT regs as novel players in SLE and advocates RORgt-directed interventions as promising therapeutic strategies.
Introduction
Systemic lupus erythematosus (SLE) is a complex and relatively common autoimmune disorder, which can affect multiple organs including skin, joints, lungs, kidneys and the central nervous system [1, 2] . As SLE causes high morbidity and mortality in a rather young collective of patients, the search for new therapeutic strategies is a priority for scientists worldwide [3, 4] . Despite intensive research, the events which lead to development of SLE and eventually cause the associated organ pathologies still remain widely elusive [5, 6] . However, a central role for CD4
1 T helper cells in disease pathogenesis has been demonstrated by multiple studies in mice and humans, including our own [7] [8] [9] [10] [11] . Recently, we and others particularly highlighted the importance of the T helper type 17/interleukin-17 (Th17/IL-17) axis for systemic autoimmunity and lupus nephritis [10, 12, 13] . Importantly, mice deficient in IL-17A or F were shown to be protected from disease in three independent studies, using the murine model of pristane-induced SLE [14] [15] [16] . Furthermore, recent studies could identify a specialized regulatory T cell subset, which is tailor-made for down-regulation of pathogenic Th17 responses [17, 18] . Lack of these T regulatory 17 (T reg 17) cells resulted in much increased SLE associated mortality and organ pathologies [19] . A crucial role for both, Th17 cells and T regs in SLE is therefore evident. Interestingly, we and others could recently describe an intriguing novel T cell subset, expressing the unusual combination of the T reg master transcription factor forkhead box protein 3 (FoxP3), together with the Th17 master regulator retinoic acid receptor-related orphan nuclear receptor gt (RORgt) [20] [21] [22] . Functional characterization revealed that these RORgt FoxP3 double-positive T cells displayed both regulatory as well as proinflammatory functions in a model of acute crescentic glomerulonephritis [22] . RORgt T cells were shown to produce the proinflammatory cytokine IL-17, but at the same time they secreted high amounts of immunoregulatory IL-10, transforming growth factor (TGF)-b and IL-35. Furthermore, they potently suppressed T effector cell (T eff ) responses in vitro, identifying them as T regs [20, 22] . Given their bi-functional properties, we proposed to name these RORgt 1 FoxP3 1 T cells 'biT regs ' . In accordance with their unique cytokine profile and transcription factor expression, biT regs showed both pro-and anti-inflammatory in-vivo functions in crescentic glomerulonephritis [22] . Exogenous biT reg transfer ameliorated renal inflammation to a similar extent as conventional RORgtnegative T regs , although the suppressive mechanisms seem to be different. Conversely, endogenous biT regs displayed additional proinflammatory functions. Interestingly, these proinflammatory biT reg functions depended upon activation of RORgt [22] . This is clinically highly relevant, as multiple pharmaceutical companies are currently developing RORgt blocking agents and some Phases I and II studies are already ongoing [23] [24] [25] . Furthermore, a landmark study which was published during preparation of this paper confirmed the biological relevance of biT regs and surprisingly identified them as potent down-regulators of anti-inflammatory Th2 immunity [26] . This effect, which might explain some of the proinflammatory biT reg functions, also depended upon activation of the transcription factor RORgt. Given their multiple immune modulatory functions, biT regs are highly likely to contribute to development of SLE. Because, however, nothing is known to date about the clinical relevance of biT regs , we decided to study their role in SLE. A major hallmark of human SLE is activation of the Type I interferon pathway, as has just recently been highlighted again [27] . We thus chose to use the pristane model of SLE, which is currently the only available murine model characterized by a strong interferon signature [28] . In particular, our study addressed the following aspects: (1) characterization of biT reg dynamics in the different organ systems affected during the course of SLE, (2) analysis of the role of RORgt in biT regs with special focus on IL-17 secretion and regulation of Th2 immunity and (3) assessment of the contribution of biT regs to organ pathologies in pristane-induced SLE.
Materials and methods

Animals
LoxP-site flanked RORC fl/fl mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). FoxP3 YFP-Cre mice were a kind gift from Alexander Y. Rudensky (Memorial Sloan-Kettering Cancer Center, New York, NY, USA). All animals used in this study were on a C57BL/6 background and were raised under specific pathogen-free conditions at our animal facility. [14, 19] . Organs were harvested between 1 week and 9 months after injection, as indicated. Animal experiments were performed according to national and institutional animal care and ethical guidelines and were approved by local committees (approval codes 37/11, 45/12, 73/14 and 07/15).
Animal experiments and functional studies
Morphological studies
Glomerular abnormalities were determined in 50 glomeruli per mouse in a blinded manner, as published previously [14, 29] . These included glomerular hypercellularity, crescent formation, fibrinoid necrosis, segmental proliferation, hyalinosis and capillary wall thickening. Lung tissue was perfused with 500 ml formalin and fixed overnight, washed with ethanol, paraffin-embedded and periodic acid-Schiff (PAS)-stained [30] . Leucocyte infiltration, granuloma formation, alveolar-wall thickening and alveolar haemorrhage were assessed in a semi-quantitative score according to the percentage of tissue affected (0-25% 5 1, 25-50% 5 2, 50-75% 5 3, >75% 5 4). Mean scores from 15 highpower fields were calculated. Numbers of pulmonary granulomas were determined in 10 low-power fields (lpf, magnification 3 100) per tissue section; their size was quantified using the Zeiss Axio Vision software (Carl Zeiss, Jena, Germany). For immunohistochemistry, tissue was stained with antibodies against CD3 (A0452; Dako, Hamburg, Germany), F4/80 (BM8; BMA Biomedicals, Hiddenhausen, Germany), MAC2 (M3/38; CedarlaneLaboratories, Burlington, ON, Canada), granulocytedifferentiation antigen-1 (GR-1) (NIMP-R14; Hycult Biotech, Uden, the Netherlands), FoxP3 (FJK-16s; eBioscience, San Diego, CA, USA) or KI67 (D3B5; Cell Signaling, Danvers, MA, USA) and developed with a polymer-based secondary antibody-alkaline phosphatase kit (POLAP; Zytomed, Berlin, Germany), as published previously. Fifty glomerular cross-sections (gcs) per kidney and 30 high-power fields (hpf, magnification 3 400) per kidney and lung section were counted in a blinded fashion.
Isolation of leucocytes from various tissues
Spleens were harvested in Hanks' balanced salt solution (HBSS) and passed through 70-mm nylon meshes. After lysis of erythrocytes, cells were washed and passed over 40-mm meshes, counted and resuspended in phosphate-buffered saline (PBS) for either culture or fluorescence activated cell sorter (FACS) analysis. Kidneys were minced and incubated in digestion medium [RPMI-1640 medium containing 10% fetal calf serum (FCS), 1% HEPES, 1% penicillin/streptomycin, 8 mg/ml collagenase D and 0Á4 mg/ml DNase] at 378C for 40 min. Kidney tissue was then homogenized using a gentle magnetic affinity cell sorter (MACS) dissociator (Miltenyi Biotech, Bergisch Gladbach, Germany) and purified using Percoll-gradient centrifugation [31] . The peritoneal cavity was washed with 5 ml ice-cold PBS to harvest cells at the indicated time-points after pristane administration [19] . For analysis of leucocytes from lungs, organs were removed, minced and incubated in digestion medium at 378C for 45 min. Tissues were then homogenized using a gentle MACS dissociator (Miltenyi Biotech), filtered over a 70-mm mesh and purified using Percoll-gradient centrifugation [30] . Peripheral blood was drawn into ethylenediamine tetraacetic acid (EDTA)-coated tubes and red blood cell lysis was performed.
Systemic humoral immune responses
Circulating anti-ds-DNA and anti-U1-ribonucleoprotein (RNP) antibodies from serum were analysed by ELISA at the indicated dilutions after coating microtitre plates with either poly-L-lysine (Sigma-Aldrich) and calf thymus DNA (Worthington) or U1-RNP (Arotec). For analysis of total non-antigen-specific immunoglobulins, ELISA plates were precoated with anti-mouse immunoglobulin (Ig)G antibodies (Jackson Immuno Research). For all analyses, serum samples were applied at the dilutions indicated. The following secondary antibodies were used for detection: total IgG, IgG1 (both Southern Biotech), IgG2b (Invitrogen), IgG2c (Bethyl) and IgG3 (Jackson Immuno Research). For detection of IgE, sera were diluted 1 : 200 and a commercially available ELISA was utilized (Biolegend, San Diego, CA, USA), following the manufacturer's instructions.
Analyses of cytokines from serum and spleen cell cultures
Splenocytes (4 3 10 6 cells/ml) were cultured under standard conditions in the presence of 1 mg/ml anti-CD3 (eBioscience, San Diego, CA, USA) and supernatants were harvested after 72 h. Commercially available ELISAs were used for detection of IFN-g and IL-17A (Biolegend). Serum was obtained from mice at 5 and 9 months after pristane induction and was analysed for levels of IL-17 and IFN-g by ELISA (Biolegend) [19] .
Flow cytometry
Cells were stained with fluorochrome-labelled antibodies against CD45, CD3, CD4, CD8, CD19, CD44, CD69, CD62L, CCR6, gdTCR, inducible T cell co-stimulator (ICOS), glucocorticoid-induced TNFR family-related gene (GITR), CD103, cytotoxic T lymphocyte-associated protein 4 (CTLA-4), CXCR3 (eBioscience), C-X-C chemokine receptor type 5 (CXCR5), programmed death 1 (PD-1), IgD, IgM, CD138 and PD-L1 (Biolegend). For intracellular and intranuclear staining, samples were processed using a commercial intranuclear staining kit (FoxP3 kit; eBioscience). Fluorochromelabelled antibodies against IL-4, IL-5, IL-13, IL-17, IFN-g, FoxP3 (eBioscience), RORgt, KI67 (both BD Biosciences, Heidelberg, Germany) and Gata-3 (Biolegend) were employed, as published recently [19, 22] . For cytokine staining, cells were activated with phorbol myristate acetate (PMA) (50 ng/ml; Sigma-Aldrich) and ionomycin (1 mg/ml; Calbiochem-Merck, Temecula, CA, USA) for 3.5 h. After 30 min of incubation, brefeldin A (10 mg/ml; Sigma-Aldrich) was added. LIVE/DEAD staining (Invitrogen Molecular Probes, Eugene, OR, USA) was used to exclude dead cells during flow cytometry. Experiments were performed on a BD LSRII Cytometer (Becton Dickinson, Heidelberg, Germany).
T reg suppression assay Cre 3 RORC fl/fl mice at the ratios indicated. Suppressive capacity was determined by IL-2 ELISA performed from the supernatants, as published recently [17, 22, 32] . For analyses of IFN-g, IL-10, IL-4, IL-13 and TNF-a in the supernatants, cytometric bead array assays were performed using a commercial kit (LEGENDplex TM mouse Th cytokine mix and match subpanel; BioLegend). To assess T eff cell proliferation, cells from the above culture experiments were harvested and analysed for their KI67 expression by FACS.
Quantitative real-time polymerase chain reaction (PCR) analysis
Total RNA of renal cortex and spleen tissue was isolated according to a standard Trizol protocol and purified utilizing a Nucleospin kit (Macherey & Nagel, D€ uren, Germany). Real-time PCR was performed after cDNA transcription as described previously (all primer sequences are available upon request) and results were normalized to expression of 18S rRNA [17] .
Statistical analyses
Results are expressed as mean 6 standard error of the mean (s.e.m.). Groups were compared by Student's t-test. A Pvalue < 0Á05 was considered statistically significant.
Results
IL-17
1 biT regs expand during systemic pristaneinduced lupus
In order to characterize more clearly the pristane model of SLE, we initially performed time-course analyses of the multiple organ manifestations. After pristane injection, mice develop acute sterile peritonitis and nonimmune complex pulmonary capillaritis. Approximately 3 weeks later, immunologically active peritoneal and pulmonary granulomas become apparent. Subsequently, autoimmunity is established with increasing serum levels of various autoantibodies, which we found to be present already in low amounts at week 8. Deposition of immune complexes then leads to progressive development of lupus nephritis which, according to our analyses, became evident by light microscopy at approximately 5 months (data not shown). In Fig. 1a a schematic overview is depicted. In order to assess the potential role of biT regs , we analysed their frequencies in multiple organs before and at different time-points after injection of pristane. biT regs were found to be present in both peritoneal lavage cells and lungs of healthy animals. In acute antigen-independent sterile peritonitis and pulmonary vasculitis, their population expanded only slightly (Fig. 1b,c) . However, at later time-points, coincident with development of peritoneal and pulmonary granulomas, biT reg percentages increased significantly (2Á5 6 0Á27% of peritoneal FoxP3
1 T regs at baseline versus 5Á56 6 0Á98% at 5 weeks and 7Á57 6 0Á99% at 8 weeks; 5Á5 6 0Á46% of pulmonary FoxP3 1 T regs at baseline, 18Á96 6 3Á17% at 5 weeks and 21Á4 6 0Á86% of FoxP3 1 T regs at week 8) (Fig. 1b,c ). In contrast, spleens which are only mildly affected during pristane-induced SLE showed merely a slight expansion of biT regs (Fig.  1d ). Finally, we studied biT regs during the course of immune complex lupus nephritis. Interestingly, our analyses revealed a distinctive pattern of renal infiltration. While only few biT regs were detected at 2 months after pristane injection (1Á3 6 0Á38% of FoxP3 1 T regs ), their frequencies increased to reach a maximum at 5 months (10Á62 6 1Á7% of FoxP3 1 T regs ). Afterwards, biT reg proportions declined steadily and were almost back to baseline levels (0Á3 6 0Á04% of FoxP3 1 T regs ) at 9 months (1Á3 6 0Á38% of FoxP3 1 T regs ) (Fig. 1e) . A significant proportion of biT regs produced IL-17 in all examined organs at all time-points ( Fig. 1b-e) . A representative FACS plot of pulmonary biT regs , including their IL-17 secretion, is shown in Fig. 1f .
RORgt activation in biT regs aggravates pulmonary capillaritis
In order to study the role of RORgt in biT regs , we generated FoxP3 Cre 3 RORC fl/fl mice, which specifically lack RORgt activation in T regs . As pristane-injected mice develop severe, often lethal, haemorrhagic pulmonary capillaritis, we first studied lung pathology in FoxP3 Cre 3 RORC fl/fl and FoxP3-Cre control mice. At 3 weeks after pristane injection, no macroscopic or histological differences were noted (Supporting information, Fig. S1a,b) . However, at later stages, when biT regs expand and pulmonary inflammation becomes granulomatous, we found striking protection of mice lacking RORgt in T regs . Macroscopic pulmonary haemorrhage was reduced significantly in FoxP3
Cre 3 RORC fl/fl mice (haemorrhage score 2Á9 6 0Á3 versus 1Á67 6 0Á3) (Fig. 2a ). In line with this, histological signs of vasculitis were ameliorated (vasculitis score 1Á63 6 0Á3 versus 0Á77 6 0Á2) (Fig. 2a) . Interestingly, granulomas were also reduced in numbers (6 6 1Á0 versus 2Á5 6 0Á6) and size (41Á23 6 4Á3 versus 26Á88 6 5Á4 3 10 3 mm 2 ) in mice with T reg -specific deficiency of RORgt (Fig.  2b) . Furthermore, our analyses revealed a significant reduction of infiltrating T cells, both by immunohistochemistry (17Á16 6 1Á6 versus 11Á52 6 1Á4 CD3
1 cells/hpf) as well as FACS analysis (55Á66 6 1Á5 versus 49Á48 6 2Á4% CD4 1 of total CD3 1 cells) of lungs (Fig. 2c) . Similarly, numbers of GR-1-positive neutrophils were also reduced in FoxP3 Cre 3 RORC fl/fl mice (9Á72 6 0Á7 versus 6Á8 6 0Á4 GR-
Lupus nephritis is ameliorated in FoxP3 Cre 3 RORC fl/fl mice
At later stages, pristane-injected mice develop proliferative immune complex glomerulonephritis. We thus studied renal disease and found significant amelioration of lupus nephritis at 9 months in FoxP3 Cre 3 RORC fl/fl mice, as evidenced by protection from glomerular injury (58Á9 6 6Á3 versus 26Á18 6 4Á4% abnormal glomeruli) (Fig. 3a) . In line with this, glomerular cell proliferation, a hallmark of lupus nephritis, was also reduced (1Á0 6 0Á07 versus 0Á67 6 0Á07 KI67 1 cells/gcs) (Fig. 3b) . Importantly, protection from histological damage also resulted in less functional injury, as indicated by lower blood urea nitrogen (BUN) levels (24Á4 6 1Á2 versus 19Á6 6 1Á6 mg/dl) (Fig. 3c) . Finally, we found that loss of RORgt activation in T regs also protected from development of albuminuria (239Á5 6 20Á4 versus 151Á7 6 18Á7 mg/g albumin per creatinine) (Fig. 3d ).
Renal inflammatory cell infiltration is reduced in mice with RORgt-deficient T regs
Because infiltrating renal leucocytes are key players of renal tissue injury, we next analysed renal inflammatory cell infiltration. In line with amelioration of renal damage, immunohistochemistry revealed a significant reduction of both glomerular (2Á9 6 0Á3 versus 1Á84 lower numbers of glomerular (3Á74 6 0Á55 versus 2Á2 6 0Á27 MAC-2 1 cells/gcs) (Fig. 4d) in biT regs on humoral immune responses. In this respect, we found unaltered levels of serum total IgG as well as identical amounts of all analysed subclasses at 9 months after pristane injection (Supporting information, Fig. S3a) . Similarly, formation of IgG autoantibodies of all subclasses against dsDNA (Fig. 5a ) as well as U1-RNP was unchanged in FoxP3 Cre 3 RORC fl/fl mice (Fig. 5b ). In line with unchanged serum antibody levels, we documented a similar immune complex deposition in kidneys of pristaneinjected mice, as evidenced by complement C3 (0Á84 6 0Á1 versus 0Á59 6 0Á05 C3 deposition score) (Fig 5c) and mouse IgG (mIgG) staining (0Á53 6 0Á06 versus 0Á46 6 0Á05 mIgG deposition score) (Fig. 5d) 
IL-17 secretion by biT regs is dependent upon RORgt
In a next step, we aimed to explore alterations of cellular immune responses. (Fig. 6c) .
RORgt deficiency alters the phenotype of T regs
In order to evaluate whether RORgt also affects intrinsic T reg functions, we studied FoxP3 protein expression on the single-cell level. Interestingly, we found significantly higher FoxP3 mean fluorescence intensities in T regs from the blood of naive FoxP3 Cre 3 RORC fl/fl mice [1376 6 24 versus 1567 6 36 FoxP3 mean fluorescence intensity (MFI)]. The same was true for T regs from both peritoneal lavage cells (702Á6 6 79Á8 versus 1212 6 200Á3 FoxP3 MFI) and lungs (500Á7 6 55Á7 versus 778Á5 6 120 FoxP3 MFI) 3 weeks after pristane injection (Fig. 7a) . Detailed analysis of T reg activation marker molecules revealed enhanced surface expression of CD103 (7Á9 6 1Á0 versus 15Á33 6 1Á7% of FoxP3 and PD-L1 remained unaffected (Fig. 7b) . In congruence with elevated expression of activation markers, we found higher T reg activation (37Á07 6 2Á6 versus 45Á53 6 0Á86% CD69 1 CD62L -and 21Á68 61Á2 versus 36Á57 6 2Á5% CD44 1 CD62L -of FoxP3 1 cells) (Fig. 7c) as well as proliferative activity (77Á09 6 2Á1 versus 83Á43 6 1Á5% KI67 1 of biT regs control Th2 immunity in a RORgt-dependent manner Next, we wanted to assess whether the observed absence of IL-17 secretion and enhanced T reg activation in FoxP3
Cre 3 RORC fl/fl mice might affect systemic immunity. We therefore analysed immune responses in the blood of naive mice. Remarkably, we found a spontaneous hyper-Th2 phenotype with an increase in Gata3 (0Á47 6 0Á04 versus 0Á69 6 0Á05% Gata3 
cells)-positive T helper cells in FoxP3
Cre 3 RORC fl/fl animals (Fig. 8a) . In line with this, we also found enhanced Th2 responses in peritoneal lavage cells (Fig. 8b, Supporting information, Fig. S5a ) and lungs (Fig. 8c) findings and also showed broad skewing towards Th2 immunity (0Á41 6 0Á08 versus 0Á73 6 0Á1% IL-4 1 , 0Á95 6 0Á14 versus 2Á0 6 0Á5% IL-5 1 and 4Á14 6 0Á2 versus 6Á62 6 0Á7% IL-13 1 among CD4 1 FoxP3 -cells) (Fig. 8d) . Conversely, Th1 and Th17 responses remained unaffected by knock-out of RORgt in T regs in all examined organs (Supporting information, Fig. S5b-f) . Similarly, serum levels of IFN-g and IL-17 were identical (Supporting information, Fig. S5g) , as was splenic and renal IFN-g mRNA expression (Supporting information, Fig. S5h ). Finally, we analysed humoral Th2 immunity and found strikingly elevated levels of IgE antibodies in serum of naive FoxP3
Cre 3 RORC fl/fl mice (358 6 26Á8 versus 801Á2 6 110 ng/ml) as well as after disease induction (670Á9 6 116 versus 1633 6 194 ng/ml) (Fig. 8e) .
Discussion
Our study aimed to evaluate the role of the newly identified RORgt 1 FoxP3 1 biT regs [20, 22, 26, 33] in systemic lupus erythematosus. As nothing is known about the occurrence and biology of these multi-potent cells in SLE, we started with a thorough analysis of the temporal and organ-specific pattern of biT reg expansion. In the first 2 weeks after pristane injection mice develop sterile peritonitis, which is mediated by innate immunity [34] . During this acute, non-autoantigendependent inflammation, biT reg levels remained at baseline. Another early and antigen-independent manifestation of pristane is acute pulmonary vasculitis with diffuse alveolar haemorrhage [35] . Similarly to peritonitis, we did not find relevant expansion of biT regs during this innate phase of pulmonary inflammation. However, the persistence of inflammatory responses after pristane injection leads to chronically progressive development of autoimmunity and formation of peritoneal and pulmonary lymphogranulomas, which became apparent from approximately 3 weeks post-injection. Interestingly, during this stage of disease, biT reg percentages increased significantly in both organs, indicating a role for establishment of granulomas and autoimmunity. In addition, these findings suggest that biT reg expansion occurs in an antigen-dependent manner, which is in full agreement with a recent report [26] . With increasing time after pristane injection, various types of autoantibodies develop [36, 37] . These are deposited in the kidneys and result in progressive immune complex-dependent lupus nephritis. During this process, renal biT regs showed a very distinct and concerted time-course. Their population started to expand early, in parallel with increasing renal inflammation and reached a maximum at approximately 5 months. Subsequently, biT reg percentages decreased slowly and were almost back to baseline levels at 9 months after pristane injection. Interestingly, this distinguished time-course of renal biT regs in chronically developing lupus nephritis parallels their dynamics in the nephrotoxic nephritis model of acute glomerulonephritis [22] . In contrast to the massive peritoneal, pulmonary and renal biT reg expansion, they increased only slightly in spleens. This concurs with the fact that pristane injection results only in a mild splenic inflammatory response. In summary, biT regs thus seem to be early mediators of adaptive inflammation and tissue injury during pristane-induced SLE. Importantly, and in accordance with previous findings by us and others [21, 22, 38, 39] , a robust fraction of biT regs produces IL-17 in all organs and at all investigated time-points. Given the observed expansion of biT regs in all affected organs, we hypothesized that biT regs might play key functional roles during SLE development. As our earlier data suggest that activation of RORgt mediates the pathogenic functions of biT regs [22] , we generated mice with selective deficiency of RORgt in FoxP3 1 T regs . In a first step, we wanted to explore whether abrogation of RORgt activation would result in protection from pulmonary vasculitis, which is a rare but lifethreatening complication of SLE in humans [40] . Analysis of lungs at an early time-point, before development of autoimmunity and expansion of biT regs , showed similar degrees of injury. However, at later stages, FoxP3
Cre 3 RORC fl/fl mice were protected significantly from pulmonary vasculitis in terms of haemorrhage, leucocyte infiltration and histological damage. Furthermore, pulmonary granulomas were reduced both in size and numbers. Next, we aimed to study the development of lupus nephritis, which is one of the most severe organ manifestations of SLE in humans and associates with a bad prognosis. In this respect, we found that FoxP3
Cre 3 RORC fl/fl mice were protected significantly, as evidenced by less histological injury and glomerular cell proliferation. In line with this, functional parameters of renal injury as serum BUN levels and albuminuria were also reduced significantly. Furthermore, we found much decreased renal proinflammatory leucocyte infiltration in mice lacking RORgt activation in T regs . Interestingly, frequencies of IL-17-producing total renal leucocytes were also reduced, despite unaltered renal Th17 responses. This indicates effects of T reg -specific RORgt deletion on IL-17 1 leucocyte populations different from Th17 cells as, for example, gdTcells and T regs themselves. In order to explore the mechanisms by which abrogation of RORgt activation in biT regs protects from SLE organ manifestations, we next assessed development of humoral autoimmunity. However, our analyses revealed unchanged levels of total serum IgG as well as all measured subclasses in FoxP3
Cre 3 RORC fl/fl mice. Similarly, serum levels of SLE characteristic anti-ds-DNA, and anti-U1-RNP autoantibodies of all subclasses remained unaltered. Consistent with unaffected serum antibodies, we found the same extent of renal complement C3 and IgG deposition in both groups of mice. In congruence, analyses of splenic B cell subpopulations, plasma cells and T follicular helper cells showed no difference.
Given the unchanged humoral autoimmunity, we next explored T cell immune responses. Strikingly, and in line with the importance of RORgt for Th17 cells [41] , proinflammatory IL-17 expression by biT regs was abrogated completely in FoxP3
Cre 3 RORC fl/fl mice. This observation might, at least in part, account for the observed amelioration of SLE-induced tissue injury. In order to identify further potential mechanisms of protection, we explored whether RORgt would also affect T reg suppression and activity. Similar to our previous data, analysing T regs from RORC pan-knock-out mice [22] , we found unchanged invitro suppressive capacity. In vivo, however, T reg -selective deletion of RORgt resulted in enhanced levels of FoxP3 protein as well as increased expression of T reg activation markers. These findings indicate that RORgt expression in T regs impairs their in-vivo regulatory function. Therefore, the high activation status of RORgt 1 biT regs , which we and others have described previously [22, 33, 42, 43] , does not seem to be induced by RORgt. Rather, additional transcription factors, which are co-activated in RORgt 1 biT regs as, for example, interferon regulatory factor (IRF)4 [26] , runtrelated transcription (Runx)1, Runx3 [42] or unknown others, might be responsible. Next, we wanted to explore whether these observed T reg alterations would result in any effects on systemic immunity. Interestingly, we found significantly elevated type 2 immune responses in naive and pristane-challenged FoxP3
Cre 3 RORC fl/fl mice, both systemically and in all inflamed target organs. Th1 and Th17 responses, in contrast, remained unaltered. Importantly, these observations are in full agreement with a very recent report, which was published during preparation of this paper [26] . This emergence of biT regs as potent regulators of type 2 immunity is particularly remarkable, as the mechanisms regulating Th2 responses remain widely unknown to date. In this regard, our data do not indicate a direct effect of biT regs on suppression of Th2 cells, as generation of Th2 immunity was not altered in our in-vitro co-culture assays of T eff with RORgt-deficient T regs . Rather, as suggested by Ohnmacht et al., indirect mechanisms, involving interactions between T regs and dendritic cells, seem to be important [26] .
Taken together, we found that biT reg selective deletion of RORgt resulted in abrogation of their IL-17 secretion, enhancement of Th2 immunity and increased T reg activation. Importantly, these changes were associated with protection from pulmonary vasculitis and lupus nephritis. It remains unclear, however, to what extent each of these three RORgt-dependent immune alterations contribute to disease amelioration. While it is likely that protection results from a mixed phenotype, involving all three mechanisms, future studies will need to address this aspect in more detail.
In summary, our study provides the first evidence, to our knowledge, for a crucial role of the newly defined biT regs in SLE. Our findings thus further support research into biT reg biology and favour RORgt-directed interventions as novel therapeutic options for SLE.
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